Opus Genetics, Inc.

Approval AI-extracted

Phentolamine Ophthalmic Solution 0.75%

presbyopia

Date

TBD

Approval decision · Date TBD estimated

What's at stake A final FDA approval decision on Phentolamine Ophthalmic Solution 0.75% for presbyopia is expected Date TBD.

Primary source · SEC 8-K verified 14h ago

“Supplemental New Drug Application (sNDA) submitted for the treatment of presbyopia, with an anticipated regulatory decision by the end of 2026.”